# DESCRIPTION

## BACKGROUND OF THE DISCLOSURE

- introduce ocular neovascularization
- describe current treatments
- motivate Ref-1/APE1 as target
- introduce APX3330

## BRIEF DESCRIPTION

- introduce APX2009 and APX2014
- describe their effects on Ref-1 function
- summarize their therapeutic potential

## DETAILED DESCRIPTION

- describe APE1 inhibitors
- detail APX2009 and APX2014
- describe their antiangiogenic effects
- explain their mechanism of action
- provide structural formulas
- describe suitable dosages
- discuss pharmaceutical compositions
- mention additional therapeutic agents
- define subject in need
- provide general definitions

## EXAMPLES

### Example 1

- introduce APX2009 and APX2014
- describe materials and methods
- synthesize compounds
- describe synthesis of (3)
- describe synthesis of (4)
- describe synthesis of (5a)
- describe synthesis of (5b)
- describe synthesis of (6a)
- describe synthesis of (6b)
- describe electrophoretic mobility shift assays
- describe cell culture and maintenance
- describe in vitro cell proliferation assay
- describe EdU incorporation, Ki-67 staining, and TUNEL
- describe cell cycle analysis and cell migration assay
- describe in vitro Matrigel tube formation assay and NF-κB p65 nuclear translocation assay
- describe choroidal sprouting assay
- describe laser-induced choroidal neovascularization
- describe in vivo imaging
- describe choroidal flatmount immunofluorescence
- describe statistical analyses
- summarize results of Ref-1 inhibitors APX2009 and APX2014
- describe blocking endothelial cell proliferation
- describe blocking S phase without inducing apoptosis
- describe blocking endothelial cell migration
- describe blocking endothelial cell tube formation
- describe inhibiting NF-κB activity
- describe blocking angiogenesis ex vivo
- describe systemic Ref-1 inhibition with APX3330
- describe systemic administration of APX2009
- discuss implications and potential therapeutic utility

### Example 2

- analyze Ref-1 knockdown effects

### Example 3

- analyze Ref-1 role in ocular angiogenesis

